Public Health Response, Forecasting, and Analytic Capacities Related to Disease Outbreaks, Epidemics, and Pandemics
Program Funding
Annual program obligations reported to SAM.gov.
Program Objective
In order to advance U.S. public health response, forecasting, and analytic capacities related to disease outbreaks, epidemics, and pandemics, the Centers for Disease Control and Prevention (CDC) established the Center for Forecasting and Outbreak Analytics (CFA). The functions of CFA are (1) Predict: Generating forecasts and analyses to support outbreak preparedness and response efforts, (2) Inform: Share timely, actionable information with the Federal government; STLT leaders, and the public, and (3) Innovate: Support research and development to improve outbreak forecasts and analyses.
Eligibility
Eligible Applicants
- Unrestricted by Entity Type
Applicant requirements will be delineated in the Notice of Funding Opportunity
How to Apply
Award Procedure
After review and approval, a notice of award is prepared and processed, along with appropriate notification to the public. Initial awards provides funds for first budget period and Notice of Award indicates support recommended for the remainder of the period of performance.
Applications will be evaluated for completeness and responsiveness by the agency program and CDC Office of Grant Services (OGS). CDC will not review incomplete and non-responsive applications. After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, and special conditions, if any.
Decision Timeline
- Approval: From 60 to 90 days
- Renewal interval: > 180 Days
Objective Review Panel
Program details & compliance
Description
CDC’s Center for Forecasting and Outbreak Analytics (CFA) harnesses cutting-edge analytics for forecasting and modeling infectious disease outbreaks to improve our country’s response capabilities during public health emergencies. Our vision is to empower people with modeling tools to save lives and protect communities from health threats.
Mission Categories
Primary: General Health and Medical
Use of Funds
Allowed Uses
Project funds may be used for costs associated with , for activities to be conducted to support public health data surveillance and analytics infrastructure modernization initiatives at the Centers for Disease Control and Prevention, and establish, expand, and maintain efforts to modernize the United States disease warning system to forecast and track hotspots for COVID–19, its variants, and emerging biological threats, including academic and workforce support for analytics and informatics infrastructure and data collection systems as described above in Section 50 and through CDC allowable and unallowable expenses. Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual.
Restrictions
Restrictions that must be considered while planning the programs and writing the budget are:
Recipients may not use funds for research.
Recipients may not use funds for clinical care except as allowed by law.
Recipients may use funds only for reasonable program purposes, including personnel, travel, supplies, and services.
Generally, recipients may not use funds to purchase furniture or equipment. Any such proposed spending must be clearly identified in the budget.
Reimbursement of pre-award costs generally is not allowed, unless the CDC provides written approval to the recipient.
Other than for normal and recognized executive-legislative relationships, no funds may be used for:
publicity or propaganda purposes, for the preparation, distribution, or use of any material designed to support or defeat the enactment of legislation before any legislative body
the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any activity designed to influence the enactment of legislation, appropriations, regulation, administrative action, or Executive order proposed or pending before any legislative body
See Additional Requirement (AR) 12 for detailed guidance on this prohibition and additional guidance on anti-lobbying restrictions for CDC recipients.
The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project outcomes and not merely serve as a conduit for an award to another party or provider who is ineligible.
Reporting & Compliance
Applicable 2 CFR 200 Subparts
- Subpart B — General Provisions
- Subpart C — Pre-Federal Award Requirements
- Subpart D — Post-Federal Award Requirements
- Subpart E — Cost Principles
- Subpart F — Audit Requirements